Get the Stockscreener App
139.84
0.78%
1.08
Ishares Biotechnology Etf stock is traded at $139.84, with a volume of 1.31M.
It is up +0.78% in the last 24 hours and up +5.27% over the past month.
See More
Previous Close:
$138.76
Open:
$139.61
24h Volume:
1.31M
Relative Volume:
0.81
Market Cap:
$9.09B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.78%
1M Performance:
+5.27%
6M Performance:
+0.67%
1Y Performance:
-4.51%
1-Day Range:
$139.25
$141.66
1-Week Range:
$137.12
$141.66
52-Week Range:
$107.43
$150.56
Ishares Biotechnology Etf Stock (IBB) Company Profile
Name
Ishares Biotechnology Etf
Sector
Industry
Phone
-
Address
-
Compare IBB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IBB
Ishares Biotechnology Etf
|
139.84 | 9.09B | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
318.18 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
645.30 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
648.51 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
252.41 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
571.97 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares Biotechnology Etf Stock (IBB) Latest News
Healthcare Stocks Move In Different Directions On Key News - Finimize
Bio-Techne Stock: Analyst Estimates & Ratings - NewsBreak: Local News & Alerts
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - sharewise.com
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - sharewise.com
The Longevity Dividend: How Financial Institutions Are Pioneering the Future of Retirement and Healthspan Investing - AInvest
Healthcare Sector's Attractive Valuations and Structural Resilience in a Post-Pandemic Recovery - AInvest
Solar, biotech, and health insurance stocks are moving on Friday: here's why - TheStreet
Stock Market: This Eye Treatment Stock Sees Sales Spike 152% As Biotech Leaders Shine - Investor's Business Daily
The Vaccine Hesitancy Dilemma: How Political and Social Hostility Threaten Biotech and Pharma Equities - AInvest
Biotech And Pharma Stocks Rally After Positive News And Upgrades - Finimize
ARKK Inflows Stay Hot - ETF.com
7 Best Biotech ETFs to Buy Now - US News Money
Should You Invest in the iShares Biotechnology ETF (IBB)? - Yahoo Finance
The Silver Dividend: Unlocking Longevity-Driven Investment Opportunities in Healthspan, AI, and Age-Friendly Infrastructure - AInvest
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - sharewise.com
The Silver Dividend: Strategic Investments in Longevity Technologies and Age-Friendly Sectors for 2025 and Beyond - AInvest
The Longevity Dividend: Investing in the Future of Healthspan Extension - AInvest
Unlocking the Longevity Dividend: Growth Stocks for the Age of Extended Lifespans - AInvest
BIO assets in stake since beginning, accumulating XP for token launch with $205,000 FDV. - AInvest
The Silver Dividend: How Aging Populations Can Drive Economic Growth and Longevity-Linked Investment Opportunities - AInvest
The Silent Crisis: Aging Populations and the Retirement Security Imperative - AInvest
💸 Is there any unusual option activity or capital flow in tech ETFs? - AInvest
Vertex Pharmaceuticals Plunges 2.69%—Is This the Bottom for Vertex Pharmaceuticals? - AInvest
Health Care Stocks Slipped As Big Players Disappointed - Finimize
Hutchmed Plummets 9.7% on Earnings Volatility: Is This a Buying Opportunity or a Warning Signal? - AInvest
Sector Update: Health Care Stocks Steady Pre-Bell Wednesday - 富途牛牛
Vertex Pharmaceuticals Plunges 19.28%—What Crisis Unfolds in Biotech's Pain Frontier? - AInvest
Vertex Pharmaceuticals Plunges 19.23%—What Storm is Brewing in Biotech? - AInvest
State-Level Innovation Resilience in a Federal Funding Vacuum - AInvest
The Longevity Dividend: Unlocking AgeTech's Potential in a World of Extended Healthspans - AInvest
The Longevity Dividend: Unlocking Investment Opportunities in an Aging World - AInvest
Health Care Stocks Take A Tumble Across The Board - Finimize
RSG Q3 EPS Forecast Lowered by National Bank Financial - Defense World
William Blair Issues Positive Outlook for SOFI Earnings - Defense World
Sen. Markwayne Mullin Purchases Shares of Zoetis Inc. (NYSE:ZTS) - Defense World
Aurora Innovation (NASDAQ:AUR) Shares Gap Up on Strong Earnings - Defense World
Rep. Robert Bresnahan, Jr. Buys JPMorgan Chase & Co. (NYSE:JPM) Stock - Defense World
Atb Cap Markets Has Negative Estimate for NOV Q3 Earnings - Defense World
LPL Financial (NASDAQ:LPLA) Shares Acquired Sen. Markwayne Mullin - Defense World
Royal Bank Of Canada Lowers NOV (NYSE:NOV) Price Target to $18.00 - Defense World
B. Riley Reaffirms “Buy” Rating for Booking (NASDAQ:BKNG) - Defense World
Q3 Earnings Forecast for Repligen Issued By Leerink Partnrs - Defense World
Rapt Therapeutics (NASDAQ:RAPT) Raised to Neutral at JPMorgan Chase & Co. - Defense World
Susquehanna Boosts Boeing (NYSE:BA) Price Target to $270.00 - Defense World
Q3 EPS Estimates for Montauk Renewables Reduced by B. Riley - Defense World
Reckitt Benckiser Group plc (LON:RKT) Insider Tamara Ingram Purchases 293 Shares of Stock - Defense World
Celestica (NYSE:CLS) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - Defense World
Q3 EPS Estimates for WM Raised by National Bank Financial - Defense World
Truist Financial Boosts Sensata Technologies (NYSE:ST) Price Target to $35.00 - Defense World
Vestcor Inc Reduces Position in National Health Investors, Inc. (NYSE:NHI) - Defense World
Victory Capital Management Inc. Buys 64,538 Shares of National CineMedia, Inc. (NASDAQ:NCMI) - Defense World
Ishares Biotechnology Etf Stock (IBB) Financials Data
There is no financial data for Ishares Biotechnology Etf (IBB). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):